<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 15 Sep 2026 07:39:13 GMT</lastBuildDate><atom:link href="https://ecency.com/created/ntla/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Analyst outperform ratings on Crispr stocks.]]></title><description><![CDATA[Cowen, Barclays and ROTH all host healthcare conferences next week; • Intellia Therapeutics (NASDAQ:NTLA) initiated with Outperform rating and $76 (158% upside) price target at JMP Securities. • CRISPR]]></description><link>https://ecency.com/@nadzry/analyst-outperform-ratings-on-crispr-stocks</link><guid isPermaLink="true">https://ecency.com/@nadzry/analyst-outperform-ratings-on-crispr-stocks</guid><category><![CDATA[crispr]]></category><dc:creator><![CDATA[nadzry]]></dc:creator><pubDate>Thu, 08 Mar 2018 13:43:42 GMT</pubDate></item></channel></rss>